PCM
KYTH

Prelude Capital Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Prelude Capital Management’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-109,923
Closed -$8.24M – 1927
2015
Q3 		$8.24M Buy
109,923
+102,548
+1,390% +$7.66M 1.2% 7
2015
Q2 		$555K Buy
+7,375
New +$395K 0.08% 287

Prelude Capital Management's KYTH Position: Q4 2015 in Review

Prelude Capital Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 109,923 shares — an estimated $8.24M sold.

Prelude Capital Management first reported a position in KYTH in Q2 2015 and held it in 2 quarters. The position peaked at $8.24M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Prelude Capital Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Prelude Capital Management sold 109,923 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $8.24M.
  • Prelude Capital Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2015 and held it in 2 quarters.
  • Prelude Capital Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $8.24M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Prelude Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.